Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Vaccines made from a peptide may make the body build an immune response to kill
tumor cells. Combining vaccine therapy with interleukin-2 and/or sargramostim may be a more
effective treatment for solid tumors.
PURPOSE: Phase II trial to study the effectiveness of vaccine therapy plus interleukin-2
and/or sargramostim in treating adults who have metastatic solid tumors.